122 related articles for article (PubMed ID: 30060700)
1. Treatment Delays in Primarily Resected Oropharyngeal Squamous Cell Carcinoma: National Benchmarks and Survival Associations.
Morse E; Judson B; Husain Z; Burtness B; Yarbrough WG; Sasaki C; Cheraghlou S; Mehra S
Otolaryngol Head Neck Surg; 2018 Dec; 159(6):987-997. PubMed ID: 30060700
[TBL] [Abstract][Full Text] [Related]
2. National treatment times in oropharyngeal cancer treated with primary radiation or chemoradiation.
Morse E; Judson B; Husain Z; Burtness B; Yarbrough W; Sasaki C; Cheraghlou S; Mehra S
Oral Oncol; 2018 Jul; 82():122-130. PubMed ID: 29909886
[TBL] [Abstract][Full Text] [Related]
3. Treatment delays in laryngeal squamous cell carcinoma: A national cancer database analysis.
Morse E; Fujiwara RJT; Judson B; Mehra S
Laryngoscope; 2018 Dec; 128(12):2751-2758. PubMed ID: 29756382
[TBL] [Abstract][Full Text] [Related]
4. Hypopharyngeal Cancer Treatment Delays: Benchmarks and Survival Association.
Morse E; Berson E; Fujiwara R; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):267-276. PubMed ID: 30324861
[TBL] [Abstract][Full Text] [Related]
5. Sex-Specific Survival and Treatment Delay in Oropharyngeal Squamous Cell Carcinoma.
Kalavacherla S; Poulhazan S; Funk E; Sacco AG; Guo T
Otolaryngol Head Neck Surg; 2024 Apr; ():. PubMed ID: 38678390
[TBL] [Abstract][Full Text] [Related]
6. Timing of Postoperative Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Squamous Cell Carcinoma.
Townsend M; DeWees T; Gross J; Daly M; Gay H; Thorstad W; Jackson RS
Otolaryngol Head Neck Surg; 2019 Aug; 161(2):297-306. PubMed ID: 31159646
[TBL] [Abstract][Full Text] [Related]
7. Treatment delays in surgically managed sinonasal cancer and association with survival.
Goel AN; Lee JT; Wang MB; Suh JD
Laryngoscope; 2020 Jan; 130(1):2-11. PubMed ID: 30835855
[TBL] [Abstract][Full Text] [Related]
8. Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival.
Morse E; Fujiwara RJT; Judson B; Mehra S
Otolaryngol Head Neck Surg; 2018 Aug; 159(2):283-292. PubMed ID: 29460669
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the Radiation Therapy Oncology Group 1221 Hypothesis: Treatment for Stage III/IV HPV-Negative Oropharyngeal Cancer.
Jacobs D; Torabi SJ; Park HS; Rahmati R; Young MR; Mehra S; Judson BL
Otolaryngol Head Neck Surg; 2021 Jun; 164(6):1240-1248. PubMed ID: 33198564
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of treatment delays in surgically managed oropharyngeal cancer and the role of human papillomavirus status.
Goel AN; Frangos M; Raghavan G; Sangar S; Lazaro S; Wang MB; Long JL; St John MA
Head Neck; 2019 Jun; 41(6):1756-1769. PubMed ID: 30615247
[TBL] [Abstract][Full Text] [Related]
11. Females Have Worse Overall and Disease-Specific Survival in Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.
Hunter WP; Harris JA; Lee CC; Cheng AC; Peacock ZS
J Oral Maxillofac Surg; 2022 Jul; 80(7):1260-1271. PubMed ID: 35469827
[TBL] [Abstract][Full Text] [Related]
12. Development and Assessment of a Novel Composite Pathologic Risk Stratification for Surgically Resected Human Papillomavirus-Associated Oropharyngeal Cancer.
Cramer JD; Dundar Y; Hotaling J; Raza SN; Lin HS
JAMA Otolaryngol Head Neck Surg; 2019 Dec; 145(12):1105-1114. PubMed ID: 31042786
[TBL] [Abstract][Full Text] [Related]
13. Patterns of Care and Comparative Effectiveness of Intensified Adjuvant Therapy for Resected Oropharyngeal Squamous Cell Carcinoma in the Human Papillomavirus Era.
Sher DJ; Nedzi L; Khan S; Hughes R; Sumer BD; Myers LL; Truelson JM; Koshy M
JAMA Otolaryngol Head Neck Surg; 2016 Aug; 142(8):777-88. PubMed ID: 27368076
[TBL] [Abstract][Full Text] [Related]
14. Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer.
Zenga J; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
Laryngoscope; 2020 Mar; 130(3):666-671. PubMed ID: 31206708
[TBL] [Abstract][Full Text] [Related]
15. Extranodal extension is a strong prognosticator in HPV-positive oropharyngeal squamous cell carcinoma.
Bauer E; Mazul A; Chernock R; Rich J; Jackson RS; Paniello R; Pipkorn P; Oppelt P; Gay H; Daly M; El-Mofty S; Thorstad W; Adkins D; Zevallos J
Laryngoscope; 2020 Apr; 130(4):939-945. PubMed ID: 31077394
[TBL] [Abstract][Full Text] [Related]
16. Impact of Lymph Node Yield on Survival in Surgically Treated Oropharyngeal Squamous Cell Carcinoma.
Gomez ED; Chang JC; Ceremsak JJ; Brody RM; Brant JA; Rassekh CH; Weinstein GS; Newman JG
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):146-156. PubMed ID: 32689888
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Delay in Treatment on Survival in Surgically Managed Sinonasal Undifferentiated Carcinoma.
Qatanani AM; Eide JG; Harris JC; Brant JA; Palmer JN; Adappa ND; Kshirsagar RS
J Neurol Surg B Skull Base; 2023 Aug; 84(4):320-328. PubMed ID: 37405245
[No Abstract] [Full Text] [Related]
18. Prognostic factors for human papillomavirus-positive and negative oropharyngeal carcinomas.
Yin LX; D'Souza G; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig EM; Ryan WR; Ha PK; Wentz A; Koch W; Eisele DW; Fakhry C
Laryngoscope; 2018 Aug; 128(8):E287-E295. PubMed ID: 29536542
[TBL] [Abstract][Full Text] [Related]
19. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
[TBL] [Abstract][Full Text] [Related]
20. Clinical vs Microscopic Extranodal Extension and Survival in Oropharyngeal Carcinoma in the Human Papillomavirus Era.
Gal TJ; O'Brien KJ; Chen Q; Huang B
Otolaryngol Head Neck Surg; 2020 May; 162(5):693-701. PubMed ID: 32151208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
